Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multiple coagulation factor deficiency 2 pseudogene 1 (MCFD2P1) is a non-coding genomic sequence classified as a pseudogene. It is related in sequence to the protein-coding MCFD2 gene, but does not encode a functional protein and has no direct biological or therapeutic role[1][3][5][6]. Pseudogenes like MCFD2P1 are typically the result of gene duplication or retrotransposition and are largely considered “genomic fossils.” While some pseudogenes have been reported to regulate their parental genes or other pathways at the RNA level, no such regulatory role has been reported for MCFD2P1 specifically[4]. Summary statement: MCFD2P1 is not a true therapeutic target; it is a pseudogene with no known function or disease relevance[1][3][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple coagulation factor deficiency 2 pseudogene 1 (MCFD2P1).